Steven W Selip, MD - Medicare Family Practice in Latrobe, PA

Steven W Selip, MD is a medicare enrolled "Family Medicine" physician in Latrobe, Pennsylvania. He graduated from medical school in 1981 and has 43 years of diverse experience with area of expertise as Family Practice. He is a member of the group practice Ars Treatment Centers Pc and his current practice location is 911 Ligonier St, Suite 101, Latrobe, Pennsylvania. You can reach out to his office (for appointments etc.) via phone at (724) 537-8518.

Steven W Selip is licensed to practice in Pennsylvania (license number MD039198L) and he also participates in the medicare program. He may accept medicare assignments (which means he may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance) and his NPI Number is 1972581734.

Contact Information

Steven W Selip, MD
911 Ligonier St, Suite 101,
Latrobe, PA 15650-1805
(724) 537-8518
(724) 537-6613



Physician's Profile

Full NameSteven W Selip
GenderMale
SpecialityFamily Practice
Experience43 Years
Location911 Ligonier St, Latrobe, Pennsylvania
Accepts Medicare AssignmentsMay be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Steven W Selip graduated from medical school in 1981
  NPI Data:
  • NPI Number: 1972581734
  • Provider Enumeration Date: 01/03/2006
  • Last Update Date: 12/28/2016
  Medicare PECOS Information:
  • PECOS PAC ID: 0244394088
  • Enrollment ID: I20090123000082

Medical Identifiers

Medical identifiers for Steven W Selip such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1972581734NPI-NPPES
0009654250003MedicaidPA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine MD039198L (Pennsylvania)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Ars Treatment Centers Pc004256813192

News Archive

FDA OKs TWi Pharmaceuticals' tentative ANDA for Guanfacine Hydrochloride Extended Release Tablets

TWi Pharmaceuticals, Inc. today announced that it has received tentative approval for its Abbreviated New Drug Application for Guanfacine Hydrochloride Extended Release Tablets 1mg, 2mg, 3mg and 4mg from the United States Food and Drug Administration.

Dalhousie University interdisciplinary cooperation leads to innovation of Femoral Fracture Reduction device

It's late at night when most of the city is sleeping and the hospital is eerily quiet. But in the operating room, a tired but undeterred surgeon is struggling through a femoral fracture reduction on a young patient. The surgery, which is usually a meticulous and straightforward procedure, is not going smoothly. After wrestling with the fracture, he has no choice but to take a more invasive approach. He cuts open the femur and reduces the fracture—if not, displaced fat and marrow could cause a fat embolism in the lungs.

U.S. FDA approval of generic Fosamax

The U.S. Food and Drug Administration today approved the first generic versions of Fosamax (alendronate sodium tablets), used to treat osteoporosis, a condition that causes thinning and weakening of a person's bones.

Radiation resistance in leukemia can be overcome by using new precision medicine, say researchers

A team of researchers led by Fatih M. Uckun, MD, PhD, of The Saban Research Institute of Children's Hospital Los Angeles and Professor at the University of Southern California Keck School of Medicine has determined that radiation resistance in leukemia can be overcome by using an engineered protein they recently designed and developed as a new precision medicine against leukemia.

Binge TV viewing increasingly prevalent - poses a threat to sleep

According to new research that looked at the TV viewing habits and sleep histories of 423 persons between ages of 18 and 25 years, binge watching or consuming multiple episodes of a TV series at one sitting can significantly affect sleep. Regular TV watching on the other hand does not affect sleep detrimentally to that extent according to study author Liese Exelmans a doctoral researcher at the University of Leuven's School of Mass Communication Research in Belgium. The study was published in the current issue of the Journal of Clinical Sleep Medicine.

Read more Medical News

› Verified 9 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Steven W Selip allows following entities to bill medicare on his behalf.
Entity NameExcela Health Physician Practices, Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1821225202
PECOS PAC ID: 6204737117
Enrollment ID: O20040322001393

News Archive

FDA OKs TWi Pharmaceuticals' tentative ANDA for Guanfacine Hydrochloride Extended Release Tablets

TWi Pharmaceuticals, Inc. today announced that it has received tentative approval for its Abbreviated New Drug Application for Guanfacine Hydrochloride Extended Release Tablets 1mg, 2mg, 3mg and 4mg from the United States Food and Drug Administration.

Dalhousie University interdisciplinary cooperation leads to innovation of Femoral Fracture Reduction device

It's late at night when most of the city is sleeping and the hospital is eerily quiet. But in the operating room, a tired but undeterred surgeon is struggling through a femoral fracture reduction on a young patient. The surgery, which is usually a meticulous and straightforward procedure, is not going smoothly. After wrestling with the fracture, he has no choice but to take a more invasive approach. He cuts open the femur and reduces the fracture—if not, displaced fat and marrow could cause a fat embolism in the lungs.

U.S. FDA approval of generic Fosamax

The U.S. Food and Drug Administration today approved the first generic versions of Fosamax (alendronate sodium tablets), used to treat osteoporosis, a condition that causes thinning and weakening of a person's bones.

Radiation resistance in leukemia can be overcome by using new precision medicine, say researchers

A team of researchers led by Fatih M. Uckun, MD, PhD, of The Saban Research Institute of Children's Hospital Los Angeles and Professor at the University of Southern California Keck School of Medicine has determined that radiation resistance in leukemia can be overcome by using an engineered protein they recently designed and developed as a new precision medicine against leukemia.

Binge TV viewing increasingly prevalent - poses a threat to sleep

According to new research that looked at the TV viewing habits and sleep histories of 423 persons between ages of 18 and 25 years, binge watching or consuming multiple episodes of a TV series at one sitting can significantly affect sleep. Regular TV watching on the other hand does not affect sleep detrimentally to that extent according to study author Liese Exelmans a doctoral researcher at the University of Leuven's School of Mass Communication Research in Belgium. The study was published in the current issue of the Journal of Clinical Sleep Medicine.

Read more Medical News

› Verified 9 days ago

Entity NameArs Treatment Centers Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1346731171
PECOS PAC ID: 0042568131
Enrollment ID: O20180807000056

News Archive

FDA OKs TWi Pharmaceuticals' tentative ANDA for Guanfacine Hydrochloride Extended Release Tablets

TWi Pharmaceuticals, Inc. today announced that it has received tentative approval for its Abbreviated New Drug Application for Guanfacine Hydrochloride Extended Release Tablets 1mg, 2mg, 3mg and 4mg from the United States Food and Drug Administration.

Dalhousie University interdisciplinary cooperation leads to innovation of Femoral Fracture Reduction device

It's late at night when most of the city is sleeping and the hospital is eerily quiet. But in the operating room, a tired but undeterred surgeon is struggling through a femoral fracture reduction on a young patient. The surgery, which is usually a meticulous and straightforward procedure, is not going smoothly. After wrestling with the fracture, he has no choice but to take a more invasive approach. He cuts open the femur and reduces the fracture—if not, displaced fat and marrow could cause a fat embolism in the lungs.

U.S. FDA approval of generic Fosamax

The U.S. Food and Drug Administration today approved the first generic versions of Fosamax (alendronate sodium tablets), used to treat osteoporosis, a condition that causes thinning and weakening of a person's bones.

Radiation resistance in leukemia can be overcome by using new precision medicine, say researchers

A team of researchers led by Fatih M. Uckun, MD, PhD, of The Saban Research Institute of Children's Hospital Los Angeles and Professor at the University of Southern California Keck School of Medicine has determined that radiation resistance in leukemia can be overcome by using an engineered protein they recently designed and developed as a new precision medicine against leukemia.

Binge TV viewing increasingly prevalent - poses a threat to sleep

According to new research that looked at the TV viewing habits and sleep histories of 423 persons between ages of 18 and 25 years, binge watching or consuming multiple episodes of a TV series at one sitting can significantly affect sleep. Regular TV watching on the other hand does not affect sleep detrimentally to that extent according to study author Liese Exelmans a doctoral researcher at the University of Leuven's School of Mass Communication Research in Belgium. The study was published in the current issue of the Journal of Clinical Sleep Medicine.

Read more Medical News

› Verified 9 days ago

Entity NameTrilogy Wellness Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1891279733
PECOS PAC ID: 5597004333
Enrollment ID: O20190222000829

News Archive

FDA OKs TWi Pharmaceuticals' tentative ANDA for Guanfacine Hydrochloride Extended Release Tablets

TWi Pharmaceuticals, Inc. today announced that it has received tentative approval for its Abbreviated New Drug Application for Guanfacine Hydrochloride Extended Release Tablets 1mg, 2mg, 3mg and 4mg from the United States Food and Drug Administration.

Dalhousie University interdisciplinary cooperation leads to innovation of Femoral Fracture Reduction device

It's late at night when most of the city is sleeping and the hospital is eerily quiet. But in the operating room, a tired but undeterred surgeon is struggling through a femoral fracture reduction on a young patient. The surgery, which is usually a meticulous and straightforward procedure, is not going smoothly. After wrestling with the fracture, he has no choice but to take a more invasive approach. He cuts open the femur and reduces the fracture—if not, displaced fat and marrow could cause a fat embolism in the lungs.

U.S. FDA approval of generic Fosamax

The U.S. Food and Drug Administration today approved the first generic versions of Fosamax (alendronate sodium tablets), used to treat osteoporosis, a condition that causes thinning and weakening of a person's bones.

Radiation resistance in leukemia can be overcome by using new precision medicine, say researchers

A team of researchers led by Fatih M. Uckun, MD, PhD, of The Saban Research Institute of Children's Hospital Los Angeles and Professor at the University of Southern California Keck School of Medicine has determined that radiation resistance in leukemia can be overcome by using an engineered protein they recently designed and developed as a new precision medicine against leukemia.

Binge TV viewing increasingly prevalent - poses a threat to sleep

According to new research that looked at the TV viewing habits and sleep histories of 423 persons between ages of 18 and 25 years, binge watching or consuming multiple episodes of a TV series at one sitting can significantly affect sleep. Regular TV watching on the other hand does not affect sleep detrimentally to that extent according to study author Liese Exelmans a doctoral researcher at the University of Leuven's School of Mass Communication Research in Belgium. The study was published in the current issue of the Journal of Clinical Sleep Medicine.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Steven W Selip is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Steven W Selip, MD
520 Jefferson Ave,
Jeannette, PA 15644-2538

Ph: (724) 527-8060
Steven W Selip, MD
911 Ligonier St, Suite 101,
Latrobe, PA 15650-1805

Ph: (724) 537-8518

News Archive

FDA OKs TWi Pharmaceuticals' tentative ANDA for Guanfacine Hydrochloride Extended Release Tablets

TWi Pharmaceuticals, Inc. today announced that it has received tentative approval for its Abbreviated New Drug Application for Guanfacine Hydrochloride Extended Release Tablets 1mg, 2mg, 3mg and 4mg from the United States Food and Drug Administration.

Dalhousie University interdisciplinary cooperation leads to innovation of Femoral Fracture Reduction device

It's late at night when most of the city is sleeping and the hospital is eerily quiet. But in the operating room, a tired but undeterred surgeon is struggling through a femoral fracture reduction on a young patient. The surgery, which is usually a meticulous and straightforward procedure, is not going smoothly. After wrestling with the fracture, he has no choice but to take a more invasive approach. He cuts open the femur and reduces the fracture—if not, displaced fat and marrow could cause a fat embolism in the lungs.

U.S. FDA approval of generic Fosamax

The U.S. Food and Drug Administration today approved the first generic versions of Fosamax (alendronate sodium tablets), used to treat osteoporosis, a condition that causes thinning and weakening of a person's bones.

Radiation resistance in leukemia can be overcome by using new precision medicine, say researchers

A team of researchers led by Fatih M. Uckun, MD, PhD, of The Saban Research Institute of Children's Hospital Los Angeles and Professor at the University of Southern California Keck School of Medicine has determined that radiation resistance in leukemia can be overcome by using an engineered protein they recently designed and developed as a new precision medicine against leukemia.

Binge TV viewing increasingly prevalent - poses a threat to sleep

According to new research that looked at the TV viewing habits and sleep histories of 423 persons between ages of 18 and 25 years, binge watching or consuming multiple episodes of a TV series at one sitting can significantly affect sleep. Regular TV watching on the other hand does not affect sleep detrimentally to that extent according to study author Liese Exelmans a doctoral researcher at the University of Leuven's School of Mass Communication Research in Belgium. The study was published in the current issue of the Journal of Clinical Sleep Medicine.

Read more News

› Verified 9 days ago


Family Medicine Doctors in Latrobe, PA

Jacob Edward Oslosky, DO
Family Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 1 Mellon Way, Latrobe, PA 15650
Phone: 724-961-0359    
Luke Egan, MD
Family Medicine
Medicare: Medicare Enrolled
Practice Location: 1 Mellon Way, Latrobe, PA 15650
Phone: 724-537-1207    
Dr. Christopher C. Drescher, M.D.
Family Medicine
Medicare: Medicare Enrolled
Practice Location: 1 Mellon Way, Latrobe, PA 15650
Phone: 724-537-1207    
Karren Vlahos, DO
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 121 W 2nd Ave, Latrobe, PA 15650
Phone: 724-537-1207    
Emily Katherine Fellin, M.D.
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1 Mellon Way, Latrobe Family Medicine Residency Program, Latrobe, PA 15650
Phone: 724-537-1485    
Dr. Francis E Meyers, D.O.
Family Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 555 Route 217, Suite 5, Latrobe, PA 15650
Phone: 724-694-0274    Fax: 724-694-0383
Dr. Anna Nash Gorman, MD
Family Medicine
Medicare: Medicare Enrolled
Practice Location: 1 Mellon Way, Latrobe, PA 15650
Phone: 724-537-1207    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.